ALEXAN

This brand name is authorized in Austria, Hong Kong, Israel, Malta, Poland, Tunisia, Turkey, South Africa

Active ingredients

The drug ALEXAN contains one active pharmaceutical ingredient (API):

1 Cytarabine UNII 04079A1RDZ - CYTARABINE

Cytarabine (ARA-C) is metabolised in vivo to ARA-CTP phosphorylated compound. This competitively inhibits DNA polymerase and may also inhibit certain acid kinase enzymes. Read about Cytarabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALEXAN Solution for injection	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC01	Cytarabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 32544, 44691
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7698
Country: MT	Medicines Authority	Identifier(s): AA565/80801
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100003751, 100003774
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6943111, 6943112
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699205770096, 8699205770102
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/26/161, T/26/162, T/26/82, T/26/83